“PhysIQ, the Department of Defense, and The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF), in conjunction with the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), announced the launch of an initiative to deploy physIQ’s platform to collect and analyze wearable sensor data to better understand the pathophysiology of COVID-19. Continuous monitoring with sophisticated personalized algorithms will be used to evaluate physiologic signals to predict disease progression and early indication of infection, and potentially evaluate novel treatments for COVID-19. This objective corresponds with JPEO-CBRND’s mission to evaluate advanced technologies for disease outbreak preparedness, as well as to understand how patients’ physiological data can be monitored remotely using continuously streaming wearable sensor data and Artificial Intelligence (AI).”
“PhysIQ, a company that specializes in collecting and analyzing continuous physiological data collected from wearable biosensors through its pinpointIQTM platform, will deploy kits to individuals associated with military hospitals in the U.S., as well as across sites in Southeast Asia. Confirmed COVID-19 positive individuals and patients at high risk of exposure will wear a clinical-grade biosensor that continuously streams data to physIQ’s platform where advanced FDA cleared AI-based analytics will process the raw vital sign data…:
“Among the specific objectives of the study are to use continuous physiological data to characterize immune response to infection, evaluate novel diagnostic and prognostic tools, and investigate efficacy of emergency investigational new drug therapies that may be administered to enrolled participants…” Read the full press release here.
Source: PhysIQ, Department of Defense, and The Henry M. Jackson Foundation for the Advancement of Military Medicine Partner to Deploy Continuous Remote Monitoring Platform to Study COVID-19 – May 7, 2020. PhysIQ.